What is it about?

SLU-PP-332 is an exercise mimetic and consequently may produce cellular adaptations that prevent severe forms of COVID-19.

Featured Image

Why is it important?

COVID-19 remains a public health problem, with new strains always emerging.

Read the Original

This page is a summary of: Can SLU-PP-332 be a new drug to prevent COVID-19?, Medical Hypotheses, June 2024, Elsevier,
DOI: 10.1016/j.mehy.2024.111362.
You can read the full text:

Read

Contributors

The following have contributed to this page